SEC Form 4 · accession 0000019446-18-000008
CANTEL MEDICAL CORP · CMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mark N. Diker
Director
Period of report
Jan 17, 2018
Accepted (ET)
Jan 19, 2018 · 4:04 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000019446
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $.10 per shareF1 | Jan 17, 2018 | S | 3,000 | $111.556 | D | 425,398 | D | |
| Common Stock, par value $.10 per shareF2 | Jan 18, 2018 | S | 2,000 | $112.0895 | D | 423,398 | D | |
| Common Stock, par value $.10 per share | holding | — | — | — | 47,724 | I | By custodial account for children |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The per share prices ranged from $111.505 to $111.556. Upon request by the Commission staff, the issuer or the reporting person will provide full information regarding the number of shares sold at each separate price.
- F2The per share prices ranged from $111.74 to $112.78. Upon request by the Commission staff, the issuer or the reporting person will provide full information regarding the number of shares sold at each separate price.